Calcium Hydroxylapatite Combined with CO₂ Ablative Fractional Laser for Atrophic Acne Scars: A Randomized Controlled Study.

Authors

Weiliang Chen, Liyuan Zhang, Xiao Luo, Chenxi Zhou, Kai Li, Xiaolei Qin

Published in

Aesthetic plastic surgery. Jul 06, 2026. Epub Jul 06, 2026.

Abstract

This study was to investigate the efficacy and safety of calcium hydroxylapatite (CaHA) filler injections combined with CO₂ ablative fractional laser (AFL) for atrophic acne scars.
A prospective, single-center, randomized controlled study was conducted on 160 participants, who were average randomly assigned to either an observation group (A) or a control group (B). Group A received two sessions of CaHA (1-month interval) after AFL 1 month, while Group B received AFL monotherapy. Efficacy was assessed by pre- and post-operation of standardized photographic images. Additionally, treatment-related adverse events (AEs) were documented.
Compared with baseline, the quantitative global scarring grading system scores decreased significantly in both groups (p < 0.001), with greater reduction observed in group A (p < 0.001). The acne scar rating scale analysis revealed the combination therapy's effectiveness across all scar subtypes (p < 0.001) and demonstrated comparable efficacy for boxcar and rolling scars (p = 1.000), both of which showed superiority to icepick scars (p < 0.001). Mild AEs are occurred in both group, such as pain, edema, crusting, and transient post-inflammatory erythema (PIE), CaHA injection may pose a risk of ecchymosis. Nevertheless, long-term PIE (lasting over 4 weeks) (p < 0.001) and post-inflammatory hyperpigmentation (p = 0.002) in group A exhibited significantly shorter healing times, accelerated healing by an average of 3.8 weeks and 3.7 weeks.
The combination of CaHA with AFL demonstrates both efficacy and safety for atrophic acne scars, particularly boxcar and rolling subtypes.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

PMID:
42410192
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.